Drug Shortage Report for FOQUEST

Last updated on 2024-03-06 History
Report ID 151791
Drug Identification Number 02470357
Brand name FOQUEST
Common or Proper name methylphenidate hydrochloride Controlled Release Capsules
Company Name ELVIUM LIFE SCIENCES
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) CAPSULE (CONTROLLED RELEASE)
Route of administration ORAL ORAL
Packaging size 60
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-01-07
Actual start date 2022-01-05
Estimated end date 2024-08-30
Actual end date
Shortage status Actual shortage
Updated date 2024-03-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3381 STEELES AVENUE EAST
TORONTO, ONTARIO
CANADA M2H 3S7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v135 2023-08-25 English Compare
v134 2023-08-16 French Compare
v133 2023-08-16 English Compare
v132 2023-08-09 French Compare
v131 2023-08-09 English Compare
v130 2023-07-27 French Compare
v129 2023-07-27 English Compare
v128 2023-07-21 French Compare
v127 2023-07-21 English Compare
v126 2023-07-17 French Compare
v125 2023-07-17 English Compare
v124 2023-06-29 French Compare
v123 2023-06-29 English Compare
v122 2023-06-28 English Compare
v121 2023-06-27 French Compare
v120 2023-06-27 English Compare
v119 2023-06-15 French Compare
v118 2023-06-15 English Compare
v117 2023-06-09 French Compare
v116 2023-06-09 English Compare

Showing 21 to 40 of 155